Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 27721 Libechov, Czech Republic.
Int J Mol Sci. 2018 Jan 18;19(1):283. doi: 10.3390/ijms19010283.
Fertilization of the mammalian oocyte requires interactions between spermatozoa and expanded cumulus extracellular matrix (ECM) that surrounds the oocyte. This review focuses on key molecules that play an important role in the formation of the cumulus ECM, generated by the oocyte-cumulus complex. In particular, the specific inhibitors (AG1478, lapatinib, indomethacin and MG132) and progesterone receptor antagonist (RU486) exerting their effects through the remodeling of the ECM of the cumulus cells surrounding the oocyte have been described. After gonadotropin stimulus, cumulus cells expand and form hyaluronan (HA)-rich cumulus ECM. In pigs, the proper structure of the cumulus ECM depends on the interaction between HA and serum-derived proteins of the inter-alpha-trypsin inhibitor (IαI) protein family. We have demonstrated the synthesis of HA by cumulus cells, and the presence of the IαI, tumor necrosis factor-alpha-induced protein 6 and pentraxin 3 in expanding oocyte-cumulus complexes (OCC). We have evaluated the covalent linkage of heavy chains of IαI proteins to HA, as the principal component of the expanded HA-rich cumulus ECM, in porcine OCC cultured in medium with specific inhibitors: AG1478 and lapatinib (both inhibitors of epidermal growth factor receptor tyrosine kinase activity); MG132 (a specific proteasomal inhibitor), indomethacin (cyclooxygenase inhibitor); and progesterone receptor antagonist (RU486). We have found that both RU486 and indomethacin does not disrupt the formation of the covalent linkage between the heavy chains of IαI to HA in the expanded OCC. In contrast, the inhibitors AG1478 and lapatinib prevent gonadotropin-induced cumulus expansion. Finally, the formation of oocyte-cumulus ECM relying on the covalent transfer of heavy chains of IαI molecules to HA has been inhibited in the presence of MG132.
哺乳动物卵母细胞的受精需要精子与卵母细胞周围扩张的卵丘细胞外基质(ECM)之间的相互作用。本篇综述主要聚焦于在卵丘细胞外基质的形成中发挥重要作用的关键分子,这些分子由卵丘复合体产生。特别是,特定抑制剂(AG1478、拉帕替尼、吲哚美辛和 MG132)和孕激素受体拮抗剂(RU486)通过重塑卵母细胞周围卵丘细胞的 ECM 发挥作用,已被描述。在促性腺激素刺激后,卵丘细胞扩张并形成富含透明质酸(HA)的卵丘 ECM。在猪中,卵丘 ECM 的适当结构取决于 HA 与血清来源的α-胰蛋白酶抑制剂(IαI)蛋白家族内的蛋白之间的相互作用。我们已经证明了卵丘细胞合成 HA,并且在扩张的卵丘-卵母细胞复合体(OCC)中存在 IαI、肿瘤坏死因子-α诱导蛋白 6 和五聚蛋白 3。我们已经评估了在含有特定抑制剂的培养基中培养的猪 OCC 中,IαI 蛋白重链与作为扩张的富含 HA 的卵丘 ECM 主要成分的 HA 之间的共价连接:AG1478 和拉帕替尼(表皮生长因子受体酪氨酸激酶活性的两种抑制剂);MG132(一种特异性蛋白酶体抑制剂)、吲哚美辛(环氧化酶抑制剂);和孕激素受体拮抗剂(RU486)。我们发现,RU486 和吲哚美辛都不会破坏在扩张的 OCC 中 IαI 重链与 HA 之间的共价连接的形成。相比之下,抑制剂 AG1478 和拉帕替尼阻止促性腺激素诱导的卵丘扩张。最后,在存在 MG132 的情况下,依赖于 IαI 分子重链向 HA 的共价转移的卵丘 ECM 的形成被抑制。